IP Library › Granted Patent US 12,207,647
Granted Patent B2
US 12,207,647 · App. 18/076,785 · Granted Jan 28, 2025

Supercooling methods for preservation of biological samples

Inventor: Xiaoxi Wei (El Cerrito, CA)
Assignee: X-Therma, Inc.
A01N1/0221A01N1/0284
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,207,647
App. No.
18/076,785
Granted
Jan 28, 2025
Kind
B2
Abstract

The present invention provides methods for cryopreserving a population of cells with improved cell viability. In some aspects, the method comprises contacting a population of cells with a peptoid polymer comprising one or more polar peptoid monomers, e.g., formulated in a cryoprotectant solution, and cooling the population of cells at a temperature of from 0° C. to about −20° C. for a time period of at least about 3 hours to produce a population of supercooled cells. The supercooling methods of the present invention provide excellent post-thaw cell survival and recovery. In certain embodiments, the population of cells is present in a tissue or an organ that is cryopreserved by performing the supercooling methods of the present invention.

Claims (25)

1. A method for preserving a biological sample or biological macromolecule, the method comprising:

(a) contacting a biological sample or biological macromolecule with a solution comprising a peptoid polymer or a salt thereof comprising one or more polar peptoid monomers; and

(b) cooling the solution to a temperature of from 0° C. to about −20° C. for a time period of at least about 3 hours to produce a preserved biological sample or preserved biological macromolecule,

wherein the peptoid polymer is present in an amount sufficient to reduce or inhibit ice crystal formation at the temperature, and

wherein the solution comprising the preserved biological sample or preserved biological macromolecule is unfrozen at the temperature.

2. The method of claim 1 , wherein the biological sample comprises a tissue, organ, or cells.

3. The method of claim 2 , wherein the tissue is a bioengineered tissue.

4. The method of claim 2 , wherein the tissue or organ is selected from the group consisting of heart, liver, lung, kidney, pancreas, intestine, thymus, cornea, bone marrow, organoids, and a combination thereof.

5. The method of claim 2 , wherein the cells are selected from the group consisting of primary cells, heart cells, liver cells, lung cells, kidney cells, pancreatic cells, gastric cells, intestinal cells, muscle cells, skin cells, neural cells, blood cells, immune cells, fibroblasts, genitourinary cells, bone cells, stem cells, sperm cells, oocytes, embryonic cells, epithelial cells, endothelial cells, and a combination thereof.

6. The method of claim 1 , wherein the biological macromolecule is selected from the group consisting of a nucleic acid, an amino acid, a protein, an isolated protein, a peptide, a lipid, a composite structure, and a combination thereof.

7. The method of claim 6 , wherein the biological macromolecule is a nucleic acid.

8. The method of claim 7 , wherein the nucleic acid is DNA or RNA.

9. The method of claim 1 , wherein the preserved biological sample or preserved biological macromolecule is in a liquid, ice-free suspension at the temperature.

10. The method of claim 1 , wherein the temperature is from about −5° C. to about −20° C.

11. The method of claim 1 , wherein the time period is at least about 8 or 16 hours.

12. The method of claim 1 , wherein the time period is from about 2 to about 5 days.

13. The method of claim 1 , wherein the time period is at least about 72 hours.

14. The method of claim 1 , wherein the peptoid polymer comprises at least 2, 3, 4, 5, 6, 7, 8, 9, 10, 15, 20, 25, or more polar peptoid monomers.

15. The method of claim 1 , wherein the one or more polar peptoid monomers have independently selected side chains comprising a hydroxyl group.

16. The method of claim 15 , wherein the independently selected side chains are optionally substituted C 1-18 hydroxyalkyl groups.

17. The method of claim 16 , wherein the C 1-18 hydroxyalkyl groups are independently selected optionally substituted C 1-6 hydroxyalkyl groups.

18. The method of claim 1 , wherein at least 2 of the polar peptoid monomers have a side chain that comprises an independently selected optionally substituted C 1-18 hydroxyalkyl group.

19. The method of claim 18 , wherein the C 1-18 hydroxyalkyl group is an independently selected optionally substituted C 1-6 hydroxyalkyl group.

20. The method of claim 1 , wherein the peptoid polymer is a peptoid-peptide hybrid or a salt thereof comprising the peptoid polymer and one or more amino acids, wherein the one or more amino acids are located at one or both ends of the peptoid polymer and/or between one or more peptoid monomers.

21. The method of claim 1 , wherein the peptoid polymer salt is selected from the group consisting of a hydrochloride salt, acetate salt, sulfate salt, phosphate salt, maleate salt, citrate salt, mesylate salt, nitrate salt, tartrate salt, gluconate salt, and a combination thereof.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 7, 2022
From: WEI, XIAOXI
To: X-THERMA, INC.
Reel/Frame 062012/0207 →
Continuity (4)
Continuation 16583895 · Sep 26, 2019
Continuation PCTUS2018027095 · Apr 11, 2018
Provisional Application 62484704 · Apr 12, 2017
Related Publication 20230292741A1 · Sep 21, 2023
References Cited (32)
US 5358931A · Rubinsky et al. · 1994 [cited by applicant]
US 11564388B2 · Wei · 2023 [cited by applicant]
US 20120046443A1 · Zuckermann et al. · 2012 [cited by applicant]
US 20130196369A1 · Hikita et al. · 2013 [cited by applicant]
US 20160309706A1 · Matsumura et al. · 2016 [cited by applicant]
JP 05503706A · 1993 [cited by applicant]
JP 2017043551A · 2017 [cited by applicant]
WO 2017017445A1 · 2017 [cited by applicant]
WO 2017066454A2 · 2017 [cited by applicant]
WO 2018191371A1 · 2018 [cited by applicant]
WO 2018191411A1 · 2018 [cited by applicant]
WO 2018232110A1 · 2018 [cited by applicant]
Claim set from copending U.S. Appl. No. 18/161,773, filed 2023. [cited by examiner]
Merriam-Webster—Comprise definition, Available Online at URL: https://www.merriam-webster.com/dictionary/comprise (Year: 2022) 7 pages. [cited by applicant]
Brittanica Online Encyclopedia—Cryopreservation, retrieved from the internet Mar. 8, 2022: Available Online at URL: https://www.britannica.com/print/article/1452607 (Year:, 2022) 3 pages. [cited by applicant]
Ahn et al., “Synthesis of Cyclic Antifreeze Glycopeptide and Glycopeptoids and Their Ice Recrystallization Inhibition Activity,” Bulletin of the Korean Chemical Society, vol. 33, No. 11, 2012, pp. 3565-3570. [cited by applicant]
Berendsen et al., “Supercooling Enables Long-Term Transplantation Survival Following 4 Days of Liver Preservation,” Nature Medicine, vol. 20, No. 7, Jun. 2014, pp. 790-794. [cited by applicant]
Bruinsma et al., “Subzero Organ Preservation: the Dawn of a New Ice Age?,” Current Opinion in Organ Transplantation, vol. 22, No. 3, Jun. 2017, pp. 281-286. [cited by applicant]
Bruinsma et al., “Supercooling Preservation of the Rat Liver for Transplantation,” Nature Protocols, vol. 10, No. 3, Feb. 18, 2015, pp. 484-494. [cited by applicant]
De Vries et al., “Supercooling Extends Preservation Time of Human Livers,” Nature Biotechnology, vol. 37, Sep. 9, 2019, pp. 1131-1136. [cited by applicant]
Deller et al., “Synthetic Polymers Enable Non-Vitreous Cellular Cryopreservation by Reducing Ice Crystal Growth During Thawing,” Nature Communications, vol. 5, Article No. 3244, Feb. 3, 2014, 7 pages. [cited by applicant]
Application No. EP18783980.8, Extended European Search Report, Mailed On Jan. 18, 2021, 12 pages. [cited by applicant]
Huang et al., “Biomimetic Peptoid Oligomers as Dual-Action Antifreeze Agents,” Proceedings of the National Academy of Sciences, vol. 109, No. 49, Dec. 4, 2012, pp. 19922-19927. [cited by applicant]
Huang et al., “Long-Term Deep-Supercooling of Large-Volume Water and Red Cell Suspensions via Surface Sealing with Immiscible Liquids,” Nature Communications, vol. 9, No. 1, Aug. 10, 2018, pp. 1-10. [cited by applicant]
Norgren et al., “On-Resin Click-Glycoconjugation of Peptoids,” Synthesis, No. 3, Jan. 9, 2009, pp. 488-494. [cited by applicant]
Okamoto et al., “Successful Sub-zero Non-freezing Preservation of Rat Lungs at −2° C. Utilizing a New Supercooling Technology,” The Journal of Heart and Lung Transplantation, vol. 27, No. 10, Oct. 2008, pp. 1150-1157. [cited by applicant]
Application No. PCT/US2018/027095, International Preliminary Report on Patentability, Mailed On Oct. 24, 2019, 9 pages. [cited by applicant]
Application No. PCT/US2018/027095, International Search Report and Written Opinion, Mailed On Sep. 12, 2018, 14 pages. [cited by applicant]
Prickett et al., “Effect of Supercooling and Cell Volume on Intracellular Ice Formation,” Cryobiology, vol. 70, 2015, pp. 156-163. [cited by applicant]
Tessier et al., “Effect of Ice Nucleation and Cryoprotectants During High Subzero-Preservation in Endothelialized Microchannels,” ACS Biomaterials Science & Engineering, vol. 4, No. 8, Jun. 26, 2018, pp. 1-25. [cited by applicant]
Usta et al., “Supercooling as a Viable Non-Freezing Cell Preservation Method of Rat Hepatocytes,” PLoS ONE, vol. 8, No. 7, e69334, Jul. 2013, pp. 1-15. [cited by applicant]
Weiwen et al., “Ice Recrystallization Inhibition Activity of Protein Mimetic Peptoids,” Journal of Inorganic and Organometallic Polymers and Materials, vol. 31, No. 1, Jul. 31, 2020, pp. 203-208. [cited by applicant]
Cited By (2)
US 12,391,799 US 12,616,191